CCI 2024 Concludes Successfully | Curad Medical Leads the Trend in Precision Tumor Embolization with Full-Stack Technologies!

"2024 Chinese College of Interventional Physicians Annual Conference (CCI 2024)" grandly opened on November 15, 2024, at the Nanjing International Youth Convention Center. The conference adhered to the principles of rich content, comprehensive fields, and staying at the forefront, covering numerous industry hotspots. It successfully completed all agendas and triumphantly concluded on November 17!

Cardiolink Science, as an innovative leader in China's tumor vascular intervention industry, takes full-stack technology as its core support. Based on therapy comprehension, the company has developed a precise embolization (AET) matrix-based comprehensive surgical instrument solution and a full solution for precise pan-vascular intervention, promoting the continuous advancement of vascular intervention therapies towards precision. During this year’s CCI, Cardiolink Science invited well-known experts from across China to host the "Insight - Full-Stack Technology Empowering Precision Symposium." Experts shared their experiences using Cardiolink's precise embolization products, exchanged insights on diagnosis and treatment practices, and discussed techniques and future trends in device application under the requirements of precise embolization. The attending experts delivered an exceptional academic feast. The event attracted numerous guests, creating a lively atmosphere, and was a complete success! Below is a review of the highlights from this meeting for our readers.

                  PART.01

Ruijie

——Full-stack Technology Empowers Precision Thematic Conference

Empower Precision

Full Stack Technology

The conference began with an opening speech by the chairman, Academician Teng Gaojun. Academician Teng extended a warm welcome to the guests attending this symposium and emphasized the significant importance of the meeting! He pointed out that TACE treatment for liver cancer is continuously evolving, with standardization and refinement gradually becoming key focuses in clinical practice. This is crucial for overcoming TACE heterogeneity, improving clinical outcomes, and benefiting patients. It is hoped that through this exchange, we can jointly promote the development and application of precise embolization techniques, providing patients with safer and more effective treatment options. Subsequently, the co-chair of the meeting, Professor Zou Yinghua, delivered an enthusiastic speech, warmly welcoming the attendees. He noted that the advancement of precise embolization technology relies on high-quality devices, and expressed hope that domestic medical device companies in China can continue to meet the evolving clinical needs of embolization interventions by offering more and better products to drive industry progress. Professor Zou concluded by wishing the conference a complete success!

Professor HaiBin Shi and Professor Feng Wang hosted the sharing and discussion in Section 1.

Professor Zhang Wen expounded on the concept and practical key points of precision embolization applied in transarterial chemoembolization (TACE) for liver cancer, including comprehensive patient management, pre-selection of TACE types, precise super-selective catheterization during the procedure, the application of CBCT, reasonable selection of embolic materials, and determination of the endpoint of embolization. Professor Zhang then pointed out, through case analysis, that precision embolization is of great significance in improving the clinical efficacy of TACE.

Professor Hu Hongtao introduced the development history of "bionic core-shell" embolic microspheres. He pointed out that the unique bionic core-shell structure brings a comprehensive improvement in performance, making this microsphere possess excellent mechanical energy absorption, rapid drug-loading capacity, and long-lasting efficacy. The developers have simultaneously laid out multiple such structural microspheres. The latest precise and uniform particle size drug-loading embolic microsphere—Yue Yuan—has made significant improvements in drug-loading capacity and particle size uniformity, making it the preferred embolic material for precision embolization surgeries.

Professor Shi Liangrong introduced the performance characteristics of 1.6F precision microcatheters and uniformly sized drug-loaded microspheres, and focused on sharing cases of using them to perform ss-TACE. In his summary, Professor Shi emphasizedIt was pointed out that the 1.6F microcatheter has a small diameter, allowing it to deeply super-selectively reach the distal end of the tumor's blood-supplying arteries. The uniformly sized drug-loaded microspheres exhibit excellent performance, completing drug loading in 1 minute, which can significantly shorten operation time. When used together, they facilitate the implementation of ss-TACE.

Professor Jinlong and Professor Wei Mu hosted the sharing and discussion in Section 2.

Professor Zheng Wenheng shared literature related to the clinical application of B-TACE.

Professor Zhang Qi first introduced the development history, clinical applications, and benefits of steerable microcatheters, as well as typical cases reported in the literature. He pointed out that a new generation of domestically produced steerable microcatheters independently developed by Chinese companies...Overcoming the previous clinical application pain points of such products, it boasts superior performance, a wide range of specifications and models, providing clinicians with an excellent new choice.。

Dr. Sun Hongtao introduced Cardiolink Science's precise embolization interventional matrix full-process solution. He pointed out that Cardiolink Science, relying on full-stack technology and based on therapy insights, has developed a precise embolization interventional matrix full-process surgical solution and a precise pan-vascular solution, leading the trend of precision development in tumor embolization interventions.

During the discussion session, guests Xie Bo, Guan Lijun, Zhao Chang, Yang Guang, Lu Dong, and Liu Chang engaged in an in-depth discussion with other participants on the content shared by the professors, and held intense discussions and exchanges on related issues.

                  PART.02

Full-stack Technology for Precision

—Precision Embolization: A Comprehensive Solution Overview